FDA Expresses Safety Concerns Over AstraZeneca Gout Drug
U.S. Food and Drug Administration scientists have determined that AstraZeneca PLC's gout medication, lesinurad, could cause serious kidney problems and potentially fatal heart conditions, according to a report released ahead of...To view the full article, register now.
Already a subscriber? Click here to view full article